Table 2.

Quantitative coronary angiography evaluation at all the four endpoints

		RVD (mm)	P	ER	P	LL (mm)	P	DS%	P
14 day
	BMS (n = 9)	2.60 ± 0.22	0.061	1.13 ± 0.14	0.067	0.32 ± 0.11	0.655	12.43 ± 4.50	0.429
	PrES (n = 10)	2.41 ± 0.31		1.25 ± 0.17		0.43 ± 0.29		19.12 ± 14.87
	SES (n = 9)	2.62 ± 0.28		1.17 ± 0.08		0.34 ± 0.21		12.99 ± 7.61
	DDES(n = 10)	2.36 ± 0.16		1.27 ± 0.09		0.36 ± 0.18		15.46 ± 8.07
28 day
	BMS (n = 8)	2.55 ± 0.39	0.994	1.19 ± 0.19	0.946	0.41 ± 0.39	0.409	18.26 ± 20.64	0.365
	PrES (n = 8)	2.56 ± 0.31		1.16 ± 0.09		0.28 ± 0.21		10.34 ± 6.93
	SES (n = 8)	2.55 ± 0.19		1.18 ± 0.12		0.18 ± 0.15		6.94 ± 5.76
	DDES(n = 8)	2.52 ± 0.38		1.20 ± 0.14		0.37 ± 0.32		15.90 ± 15.14
90 day
	BMS (n = 8)	2.37 ± 0.30	0.945	1.26 ± 0.13	0.662	0.76 ± 0.36	0.767	32.71 ± 16.40	0.809
	PrES (n = 8)	2.30 ± 0.22		1.29 ± 0.08		0.85 ± 0.44		37.19 ± 18.71
	SES (n = 8)	2.30 ± 0.27		1.29 ± 0.10		0.83 ± 0.34		35.45 ± 15.47
	DDES(n = 8)	2.34 ± 0.18		1.24 ± 0.10		0.96 ± 0.35		41.66 ± 15.79
191 day
	BMS (n = 9)	2.41 ± 0.30	0.335	1.28 ± 0.16	0.368	0.34 ± 0.31	0.079	15.76 ± 16.68	0.811
	PrES (n = 9)	2.31 ± 0.29		1.24 ± 0.14		0.62 ± 0.34		27.44 ± 16.22
	SES (n = 9)	2.31 ± 0.19		1.30 ± 0.10		0.41 ± 0.25		18.01 ± 11.28
	DDES(n = 9)	2.52 ± 0.31		1.19 ± 0.11		0.72 ± 0.36		29.70 ± 15.11

RVD reference vessel diameter, ER expansion ratio, LL lumen loss, DS% diameter stenosis %, BMS Bare-Metal Stents, PrES Probucol-Eluting Stents, SES Sirolimus-Eluting Stents, DDES Dual Drug-Eluting Stents